As of Oct 18
| -0.06 / -0.58%|
The 3 analysts offering 12-month price forecasts for Edge Therapeutics Inc have a median target of 19.00, with a high estimate of 21.00 and a low estimate of 17.00. The median estimate represents a +86.27% increase from the last price of 10.20.
The current consensus among 3 polled investment analysts is to Buy stock in Edge Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.